Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,000,412
+$99,742 QoQ
Shares Held
2,014
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#851
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Argent Trust Co holds $4,756,008 across 11 Biotechnology names. VRTX ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,749 | $1,090,571 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,014 | $1,000,412 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
1,426 | $530,001 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
1,220 | $385,629 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
5,598 | $307,553 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,174 | $287,359 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
3,018 | $239,296 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
2,679 | $232,938 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,000,412 | 2,014 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $900,670 | 2,017 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $971,549 | 2,143 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $854,948 | 2,183 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,067,588 | 2,398 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,407,916 | 2,904 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,326,492 | 3,294 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,531,507 | 3,293 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,520,526 | 3,244 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,348,081 | 3,225 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,223,924 | 3,008 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $896,125 | 2,577 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $875,199 | 2,487 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $711,742 | 2,259 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $652,352 | 2,259 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $686,498 | 2,371 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $679,394 | 2,411 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $629,198 | 2,411 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $606,315 | 2,761 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $418,465 | 2,307 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $491,371 | 2,437 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $413,877 | 1,926 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $509,548 | 2,156 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $522,197 | 1,919 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $562,330 | 1,937 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $530,152 | 2,228 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||